WebJan 11, 2024 · Contact: Cytokinetics MD: 650-624-2929: [email protected]: Locations. Show 105 study locations Sponsors and Collaborators ... Ji Xing Pharmaceuticals (Shanghai) Co., Ltd. Investigators. Layout table for investigator information; Study Director: Cytokinetics MD: Cytokinetics: WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have ...
Cytokinetics Muscle Biology Therapies Company
WebApr 29, 2004 · Cytokinetics is registered under the ticker NASDAQ:CYTK . Their stock opened with $13.00 in its Apr 29, 2004 IPO. Cytokinetics is funded by 5 investors. Royalty Pharma and Deerfield are the most recent investors. Cytokinetics has invested in The Mended Hearts on Jan 30, 2024. This investment - Grant - The Mended Hearts - was … WebDec 9, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. e and m motors swalwell
CYTK Cytokinetics Inc. Stock Overview (U.S.: Nasdaq) Barron
WebApr 10, 2024 · The company’s shares closed last Thursday at $78.78. Kumar covers the Healthcare sector, focusing on stocks such as Cytokinetics, Syndax Pharmaceuticals, and Fulcrum Therapeutics. According to... WebJul 19, 2024 · News of the positive study findings sent Cytokinetics stock higher by nearly 50% Monday, surpassing the price shares traded at before another, ... Despite losing its big pharma partner, Cytokinetics still intends to seek FDA approval of the drug. And the biotech's future looks brighter after CK-274 showed encouraging signs of working as ... WebNov 30, 2024 · PDUFA Target Action Date Set for November 30, 2024. FDA is Currently Not Planning to Hold an Advisory Committee Meeting to Discuss the Application SOUTH SAN FRANCISCO, Calif., Feb. 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) has … csr australia pty ltd